Novel Therapies for Managing Cholestasis.

Journal

Clinical liver disease

ISSN: 2046-2484

Titre abrégé: Clin Liver Dis (Hoboken)

Pays: United States

ID NLM: 101597441

Informations de publication

Date de publication:
Mar 2020

Historique:

received: 08 06 2019

accepted: 21 09 2019

entrez: 8 4 2020

pubmed: 8 4 2020

medline: 8 4 2020

Statut: epublish

Résumé

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-3-reading-santiago a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-3-interview-levy an interview with the author https://www.wileyhealthlearning.com/Activity/7058605/disclaimerspopup.aspx quertions and earn CME.

Identifiants

DOI: 10.1002/cld.886 PMID: 32257119 PMC: PMC7128034

pubmed: 32257119

doi: 10.1002/cld.886

pii: CLD886

pmc: PMC7128034

doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

95-99

Informations de copyright

Références

J Clin Gastroenterol. 2017 Feb;51(2):e11-e16

pubmed: 27428727

Aliment Pharmacol Ther. 2011 Jan;33(2):235-42

pubmed: 21083674

Hepatology. 2019 Jan;69(1):394-419

pubmed: 30070375

Hepatology. 2019 Sep;70(3):788-801

pubmed: 30661255

Lancet Gastroenterol Hepatol. 2017 Oct;2(10):716-726

pubmed: 28818518

Hepatology. 2019 Feb;69(2):684-698

pubmed: 30153359

N Engl J Med. 2016 Aug 18;375(7):631-43

pubmed: 27532829

J Hepatol. 2017 Sep;67(3):549-558

pubmed: 28529147